The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
TGF-β 1/Smads and miR-21 in Renal Fibrosis and Inflammation
Open accessAbstract
Renal fibrosis, irrespective of its etiology, is a final common stage of almost all chronic kidney diseases. Increased apoptosis, epithelial-to-mesenchymal transition, and inflammatory cell infiltration characterize the injured kidney. On the molecular level, transforming growth factor-β 1 (TGF-β 1)-Smad3 signaling pathway plays a central role in fibrotic kidney disease. Recent findings indicate the prominent role of microRNAs, small noncoding RNA molecules that inhibit gene expression through the posttranscriptional repression of their target mRNAs, in different pathologic conditions, including renal pathophysiology. miR-21 was also shown to play a dynamic role in inflammatory responses and in accelerating injury responses to promote organ failure and fibrosis. Understanding the cellular and molecular bases of miR-21 involvement in the pathogenesis of kidney diseases, including inflammatory reaction, could be crucial for their early diagnosis. Moreover, the possibility of influencing miR-21 level by specific antagomirs may be considered as an approach for treatment of renal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chung, A. C. K., Dong, Y., Yang, W., Zhong, X., Li, R., & Lan, H. Y. (2012) · Molecular Therapy · doi:10.1038/mt.2012.251 · Cited by 152
RetractedMolecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Identification of tissue-specific microRNAs from mouse
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., & Tuschl, T. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00809-6 · Cited by 3,355
Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system
Massague, J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1745 · Cited by 1,966
Massagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,899
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,780
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
Wynn, T. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31487 · Cited by 1,456
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209414109 · Cited by 1,434
SMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244
Diversifying microRNA sequence and function
Ameres, S. L., & Zamore, P. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3611 · Cited by 1,175
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005
Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., & Arteaga, C. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005912200 · Cited by 992
Sorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. J., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., et al. (1999) · Nature Cell Biology · doi:10.1038/12971 · Cited by 911
Yang, X. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00479-08 · Cited by 888 · cited 1×
“In fact, this relationship has been alreadywell documented in cancers [73, 74].”
BackgroundSato, M., Muragaki, Y., Saika, S., Roberts, A. B., & Ooshima, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19270 · Cited by 831
TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
Wu, M. Y., & Hill, C. S. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.02.012 · Cited by 746
Oh, J., Takahashi, R., Kondo, S., Mizoguchi, A., Adachi, E., Sasahara, R. M., Nishimura, S., Imamura, Y., Kitayama, H., Alexander, D. B., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00597-9 · Cited by 728
Crystal Structure of a Smad MH1 Domain Bound to DNA
Shi, Y., Wang, Y.-F., Jayaraman, L., Yang, H., Massagué, J., & Pavletich, N. P. (1998) · Cell · doi:10.1016/s0092-8674(00)81600-1 · Cited by 725
Inflammatory processes in renal fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.114 · Cited by 690
Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., & Gelbart, W. M. (1995) · Genetics · doi:10.1093/genetics/139.3.1347 · Cited by 669
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Smad2 role in mesoderm formation, left–right patterning and craniofacial development
Nomura, M., & Li, E. (1998) · Nature · doi:10.1038/31693 · Cited by 599
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
TGF-β/Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
Qin, W., Chung, A. C. K., Huang, X. R., Meng, X.-M., Hui, D. S. C., Yu, C.-M., Sung, J. J. Y., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121308 · Cited by 566
Savage, C., Das, P., Finelli, A. L., Townsend, S. R., Sun, C. Y., Baird, S. E., & Padgett, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.790 · Cited by 523
Sirard, C., de la Pompa, J. L., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S., Wakeham, A., Schwartz, L., Kern, S. E., et al. (1998) · Genes & Development · doi:10.1101/gad.12.1.107 · Cited by 502
Gomez, I. G., MacKenna, D. A., Johnson, B. G., Kaimal, V., Roach, A. M., Ren, S., Nakagawa, N., Xin, C., Newitt, R., Pandya, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75852 · Cited by 413
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
Song, L.-B., Li, J., Liao, W.-T., Feng, Y., Yu, C.-P., Hu, L.-J., Kong, Q.-L., Xu, L.-H., Zhang, X., Liu, W.-L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39374 · Cited by 398
How the Smads regulate transcription
Ross, S., & Hill, C. S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.09.006 · Cited by 383
Smad Proteins Bind a Conserved RNA Sequence to Promote MicroRNA Maturation by Drosha
Davis, B. N., Hilyard, A. C., Nguyen, P. H., Lagna, G., & Hata, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.07.011 · Cited by 383
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition
McDonald, O. G., Wu, H., Timp, W., Doi, A., & Feinberg, A. P. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2084 · Cited by 379
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
Zhong, X., Chung, A. C. K., Chen, H. Y., Dong, Y., Meng, X. M., Li, R., Yang, W., Hou, F. F., & Lan, H. Y. (2013) · Diabetologia · doi:10.1007/s00125-012-2804-x · Cited by 355
miR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
Moriyama, T., Ohuchida, K., Mizumoto, K., Yu, J., Sato, N., Nabae, T., Takahata, S., Toma, H., Nagai, E., & Tanaka, M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0592 · Cited by 342
Khalil, N. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00259-2 · Cited by 341
TGF-β in Renal Injury and Disease
Böttinger, E. P. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.009 · Cited by 339
Smad2 Protects against TGF-β/Smad3-Mediated Renal Fibrosis
Meng, X. M., Huang, X. R., Chung, A. C. K., Qin, W., Shao, X., Igarashi, P., Ju, W., Bottinger, E. P., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009121244 · Cited by 338
TGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
Samarakoon, R., Overstreet, J. M., & Higgins, P. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.10.003 · Cited by 332
Zhou, J., Wang, K.-C., Wu, W., Subramaniam, S., Shyy, J. Y.-J., Chiu, J.-J., Li, J. Y.-S., & Chien, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107052108 · Cited by 325
Yang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258
Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg
Stockis, J., Colau, D., Coulie, P. G., & Lucas, S. (2009) · European Journal of Immunology · doi:10.1002/eji.200939684 · Cited by 252
Identification of a microRNA signature in renal fibrosis: role of miR-21
Zarjou, A., Yang, S., Abraham, E., Agarwal, A., & Liu, G. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00273.2011 · Cited by 241
Signaling Mechanism of TGF-β1 in Prevention of Renal Inflammation: Role of Smad7
Wang, W., Huang, X. R., Li, A. G., Liu, F., Li, J.-H., Truong, L. D., Wang, X. J., & Lan, H. Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004121070 · Cited by 236
miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7
McClelland, A. D., Herman-Edelstein, M., Komers, R., Jha, J. C., Winbanks, C. E., Hagiwara, S., Gregorevic, P., Kantharidis, P., & Cooper, M. E. (2015) · Clinical Science · doi:10.1042/cs20150427 · Cited by 235
Wang, S., Meng, X.-M., Ng, Y.-Y., Ma, F. Y., Zhou, S., Zhang, Y., Yang, C., Huang, X.-R., Xiao, J., Wang, Y.-Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6604 · Cited by 235
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
Chen, H. Y., Huang, X. R., Wang, W., Li, J. H., Heuchel, R. L., Chung, A. C. K., & Lan, H. Y. (2011) · Diabetes · doi:10.2337/db10-0403 · Cited by 225
Stability of miRNA in Human Urine Supports its Biomarker Potential
Mall, C., Rocke, D. M., Durbin-Johnson, B., & Weiss, R. H. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.44 · Cited by 224
Inazaki, K., Kanamaru, Y., Kojima, Y., Sueyoshi, N., Okumura, K., Kaneko, K., Yamashiro, Y., Ogawa, H., & Nakao, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00779.x · Cited by 217
Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis
Glowacki, F., Savary, G., Gnemmi, V., Buob, D., Van der Hauwaert, C., Lo-Guidice, J.-M., Bouyé, S., Hazzan, M., Pottier, N., Perrais, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058014 · Cited by 205
Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse
Yaswen, L., Kulkarni, A., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., Longenecker, G., Mozes, E., & Karlsson, S. (1996) · Blood · doi:10.1182/blood.v87.4.1439.bloodjournal8741439 · Cited by 204
The latent transforming growth factor β binding protein (LTBP) family
Öklü, R., & Hesketh, R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520601 · Cited by 193
Clinical applications of microRNAs
Hydbring, P., & Badalian‐Very, G. (2013) · F1000Research · doi:10.12688/f1000research.2-136.v3 · Cited by 192
Meng, X.-M., Huang, X. R., Xiao, J., Chung, A. C. K., Qin, W., Chen, H.-Y., & Lan, H. Y. (2012) · Kidney International · doi:10.1038/ki.2011.327 · Cited by 179
Vindevoghel, L., Lechleider, R. J., Kon, A., de Caestecker, M. P., Uitto, J., Roberts, A. B., & Mauviel, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14769 · Cited by 179
Vettori, S., Gay, S., & Distler, O. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010130 · Cited by 172
MicroRNA‐21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice
Zhang, Z., Peng, H., Chen, J., Chen, X., Han, F., Xu, X., He, X., & Yan, N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.021 · Cited by 168
Weiher, H., Noda, T., Gray, D. A., Sharpe, A. H., & Jaenisch, R. (1990) · Cell · doi:10.1016/0092-8674(90)90008-3 · Cited by 167
Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.
Kulkarni, A. B., Ward, J. M., Yaswen, L. R., Mackall, C. L., Bauer, S. R., Huh, C.-G., Gress, R. E., & Karlsson, S. (1995) · PubMed · Cited by 166
Urinary miR-21, miR-29, and miR-93: Novel Biomarkers of Fibrosis
Wang, G., Kwan, B. C., Lai, F. M., Chow, K. M., Li, P. K., & Szeto, C. (2012) · American Journal of Nephrology · doi:10.1159/000343452 · Cited by 156
MicroRNA-21 in Glomerular Injury
Lai, J. Y., Luo, J., O'Connor, C. L., Jing, X., Nair, V., Ju, W., Randolph, A. E., Ben‐Dov, I. Z., Matar-Ujvary, R., Briskin, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121274 · Cited by 145
Effect of miR-21 on Renal Fibrosis by Regulating MMP-9 and TIMP1 in kk-ay Diabetic Nephropathy Mice
Wang, J., Gao, Y., Ma, M.-F., Li, M., Zou, D., Yang, J., Zhu, Z., & Zhao, X. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9539-2 · Cited by 144
Clinical applications of microRNAs
Hydbring, P., & Badalian‐Very, G. (2013) · F1000Research · doi:10.12688/f1000research.2-136.v1 · Cited by 140
Smad‐mediated regulation of microRNA biosynthesis
Blahna, M. T., & Hata, A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.01.041 · Cited by 139
Mechanism of chronic aristolochic acid nephropathy: role of Smad3
Zhou, L., Fu, P., Huang, X. R., Liu, F., Chung, A. C. K., Lai, K. N., & Lan, H. Y. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00675.2009 · Cited by 136
Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
Morrissey, J. J., Ishidoya, S., McCracken, R., & Klahr, S. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7102202 · Cited by 135
Zhang, Z., Zha, Y., Hu, W., Huang, Z. D., Gao, Z., Zang, Y., Chen, J., Dong, L., & Zhang, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517953 · Cited by 129
Latent TGF-β1 Protects Against Crescentic Glomerulonephritis
Huang, X. R., Chung, A. C. K., Zhou, L., Wang, X. J., & Lan, H. Y. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040484 · Cited by 120
Considering Exosomal miR-21 as a Biomarker for Cancer
Shi, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5040042 · Cited by 113
MicroRNAs as biomarkers of disease onset
Cieśla, M., Skrzypek, K., Kozakowska, M., Łoboda, A., Józkowicz, A., & Dulak, J. (2011) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-011-5001-8 · Cited by 106
Self-citationStachurska, A., Cieśla, M., Kozakowska, M., et al. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200456 · Cited by 103
Smad3 mediates ANG II-induced hypertensive kidney disease in mice
Liu, Z., Huang, X. R., & Lan, H. Y. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00595.2011 · Cited by 101
Smad3 regulates E-cadherin via miRNA-200 pathway
Ahn, S.-M., Cha, J.-Y., Kim, J., Kim, D., Trang, H. T. H., Kim, Y.-M., Yh, C., Park, D., & Hong, S. (2011) · Oncogene · doi:10.1038/onc.2011.484 · Cited by 98
Kindlin-2 Mediates Activation of TGF-β/Smad Signaling and Renal Fibrosis
Wei, X., Xia, Y., Li, F., Tang, Y., Nie, J., Liu, Y., Zhou, Z., Zhang, H., & Hou, F. F. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012101041 · Cited by 98
Boesch, C., Łoboda, A., Józkowicz, A., Huebbe, P., Blank, R., Wolffram, S., Dulak, J., & Rimbach, G. H. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.04.023 · Cited by 87
Self-citationLi, S., Mariappan, N., Megyesi, J. K., Shank, B. B., Kannan, K., Theus, S. A., Price, P. M., Duffield, J. S., & Portilla, D. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00309.2013 · Cited by 86
Zhou, Y., Xiong, M., Fang, L., Jiang, L., Wen, P., Dai, C., Zhang, C., & Yang, J. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.06.032 · Cited by 70
Circulating MicroRNAs as Biomarkers in Health and Disease
Velu, V. K. (2012) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2012/4901.2653 · Cited by 65
Bao, H., Hu, S., Zhang, C., Shi, S., Qin, W., Zeng, C., Zen, K., & Liu, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.065 · Cited by 63
Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4+ T cells
Hahn, S. A., Stahl, H. F., Becker, C., Correll, A., Schneider, F.-J., Tuettenberg, A., & Jonuleit, H. (2013) · Blood · doi:10.1182/blood-2012-12-474478 · Cited by 62
Versatile microRNA biogenesis in animals and their viruses
Xie, M., & STEITZ, J. A. (2014) · RNA Biology · doi:10.4161/rna.28985 · Cited by 61
Androsavich, J. R., Chau, B. N., Bhat, B., Linsley, P. S., & Walter, N. G. (2012) · RNA · doi:10.1261/rna.033308.112 · Cited by 54
Molecular events in matrix protein metabolism in the aging kidney
Sataranatarajan, K., Féliers, D., Mariappan, M. M., Lee, H. J., Lee, M. J., Day, R. T., Yalamanchili, H. B., Choudhury, G. G., Barnes, J. L., Remmen, H. V., et al. (2012) · Aging Cell · doi:10.1111/acel.12008 · Cited by 52
Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury
Nakayama, Y., Ueda, S., Yamagishi, S., Obara, N., Taguchi, K., Ando, R., Kaida, Y., Iwatani, R., Kaifu, K., Yokoro, M., et al. (2013) · Kidney International · doi:10.1038/ki.2013.398 · Cited by 48
Fibrosis causes progressive kidney failure
Cohen, E. P. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90221-x · Cited by 47
Akt promotes Endocardial-Mesenchyme Transition
Meadows, K. N., Iyer, S., Stevens, M. V., Wang, D., Shechter, S., Perruzzi, C. A., Camenisch, T. D., & Benjamin, L. E. (2009) · Vascular Cell · doi:10.1186/2040-2384-1-2 · Cited by 44
Serum miR-21 may be a Potential Diagnostic Biomarker for Diabetic Nephropathy
Wang, J., Duan, L., Tian, L., Liu, J., Wang, S., Gao, Y., & Yang, J. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1565095 · Cited by 43
MicroRNA21 promotes interstitial fibrosis via targeting DDAH1: a potential role in renal fibrosis
Liu, X., Hong, Q., Wang, Z., Yu, Y., Zou, X., & Xu, L. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2580-2 · Cited by 40
Zhao, C., Li, T., Han, B., Yue, W., Shi, L., Wang, H., Guo, Y., & Lu, Z. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.01.015 · Cited by 40
Cyclosporine-mediated allograft fibrosis is associated with micro-RNA-21 through AKT signaling
Chen, J., Zmijewska, A. A., Zhi, D., & Mannon, R. B. (2014) · Transplant International · doi:10.1111/tri.12471 · Cited by 34
Dai, C., Wen, X., He, W., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174821 · Cited by 32
Differential effects of Smad3 targeting in a murine model of chronic kidney disease
Kellenberger, T., Krag, S. R. P., Danielsen, C. C., Wang, X., Nyengaard, J. R., Pedersen, L., Yang, C., Gao, S., & Wogensen, L. (2013) · Physiological Reports · doi:10.1002/phy2.181 · Cited by 17
Prediction of novel isoforms of the mouse Mpv17l protein
Magoulas, C., Jasim, A., & Heredia, L. (2009) · Genome · doi:10.1139/g09-061 · Cited by 2
Cited by
New insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D.-Q., Wang, Y.-N., Feng, Y.-L., Cao, G., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,179
Targeting the progression of chronic kidney disease
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., & Rodrigues-Diez, R. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0248-y · Cited by 979
Chen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
New progress in drugs treatment of diabetic kidney disease
Wang, J., Xiang, H., Lu, Y., Wu, T., & Ji, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111918 · Cited by 74
Sirtuins at the Service of Healthy Longevity
Watroba, M., & Szukiewicz, D. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.724506 · Cited by 64
Metadata
- Authors
- Loboda, A., Sobczak, M., Jozkowicz, A., & Dulak, J.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W2517894941
- Cited by
- 297
- References
- 105
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.